MedTrace Logo

Omega 3 and Ischemic Stroke; Fish Oil as an Option

NCT04386525 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-05-14

No results posted yet for this study

Summary

In this trial, The investigators are going to investigate the improvement of neurological functions and infarced area of the brain in ischemic stroke patients after ingestion of omega 3 products that have high concentrations of DHA and EPA in comparison to control group. The study will assess the improvement by computerized calculation of the size of the infarcted area before and after the intervention and neurological assessment tools. The researchers will follow the scientific and ethical regulations prevent any harmful effect on recruited subjects.

Conditions

  • Ischemic Stroke
  • Neurological Injury
  • Stroke, Acute
  • Inflammatory Response
  • Permanent Injury
  • Neurologic Dysfunction
  • Neurological Disorder
  • Brain Ischemia
  • Brain Injuries

Interventions

DIETARY_SUPPLEMENT

Omega-3 fish oil

soft gels,1000gm, 84% of DHA and EPA

Sponsors & Collaborators

  • King Fahad Medical City

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-12-30
Completion
2022-02-01
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04386525 on ClinicalTrials.gov